Treating Spina bifida - blog image
Celvi Blog Post Image - Bioprinting in regenerative medicine

In The Press

Bereamail.co.za - Celvi Article Image
The Sunflower Fund - Media Release Feautured Image
Greytown Gazette - Article Image
Gizelle's Story - A Mothers Gift


We’d love to hear from you. Share your videos and photos through Facebook & Instagram using #CelviStories

Join our Facebook & Instagram Communities to connect with the CELVI family and keep up to date with developments and exciting events.

Something is wrong.
Instagram token error.
Load More

M-D-05.10 V1 – 2019/09/09

Are you pregnant?

Sign up for educational information about cord blood banking

The treating doctor will determine the use of cord blood for treatment, depending on many factors, including the patient’s medical condition, the quality of the cord blood sample, if the patient’s own cord blood can be used or an adequately matched donor’s cord blood.The use of cord blood has been established in stem cell transplantation and has been used to treat more than 80 diseases. The use of cord blood in regenerative medicine is still being researched and there is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.The use of cord tissue stem cells is still in early research stages, and there is no guarantee that treatments using cord tissue stem cells will be available in the future. Cord tissue stem cells are found in the cord tissue which is stored whole. Additional processing will be required to isolate the stem cells from the tissue for use. CELVI (Pty) Ltd outsources all cord blood and tissue processing and storage activities to Next Biosciences in Midrand, South Africa, a licensed and AABB accredited facility.

Notice: Click here to go to the South African COVID-19 Portal